Filing Details

Accession Number:
0001209191-18-003008
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-01-09 18:00:15
Reporting Period:
2018-01-05
Accepted Time:
2018-01-09 18:00:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
897448 Amarin Corp Plc AMRN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1289884 B Steven Ketchum C/O Amarin Pharma, Inc.
1430 Route 206
Bedminster NJ 07921
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2018-01-05 64,683 $2.04 206,480 No 4 M Direct
Ordinary Shares Disposition 2018-01-05 64,683 $4.40 141,797 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Ordinary Shares Stock Option (right to buy) Disposition 2018-01-05 64,683 $0.00 64,683 $2.04
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
137,817 2024-01-08 No 4 M Direct
Footnotes
  1. The exercise and sale transaction reported in the Form 4 is made pursuant to a Rule 10b5-1 plan.
  2. The Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.40 to $4.41, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of Ordinary Shares sold at each separate price.
  4. Please see the section titled "Remarks" below for additional information.
  5. On January 8, 2014, the Reporting Person was granted an option to purchase 202,500 Ordinary Shares under the Amarin Corporation plc 2011 Stock Incentive Plan. The shares subject to this option are fully vested and exercisable as of the date of this Form 4.